Publications

1. de Conti A, Madia F, Schubauer-Berigan MK, Benbrahim-Tallaa L (2025). Carcinogenicity of some metals evaluated by the IARC Monographs: a synopsis of the evaluations of arsenic, cadmium, cobalt, and antimony. Toxicol Appl Pharmacol. 504:117506. https://doi.org/10.1016/j.taap.2025.117506 PMID:40780533
2. Turner MC, Basagaña X, Albin M, Broberg K, Burdorf A, van Daalen KR, et al. (2025). Occupational health in the era of climate change and the green transition: a call for research. Lancet Reg Health Eur. 54:101353. https://doi.org/10.1016/j.lanepe.2025.101353 PMID:40613104
3. DeMarini D, Gwinn W, Watkins E, Reisfeld B, Chiu WA, Zeise L, et al. (2025). IARC workshop on the key characteristics of carcinogens: assessment of endpoints for evaluating mechanistic evidence of carcinogenic hazards. Environ Health Perspect. 133(2):25001. https://doi.org/10.1289/ehp15389 PMID:39899356
4. Berrington de González A, Masten SA, Bhatti P, Fortner RT, Peters S, Santonen T, et al. (2024). Advisory Group recommendations on priorities for the IARC Monographs. Lancet Oncol. 25(5):546–8. https://doi.org/10.1016/S1470-2045(24)00208-0 PMID:38621402
5. Middleton DRS, Wedekind R, Hall AL, Suonio E, DeBono NL, Vermeulen RCH, et al. (2024). Critical reviews of exposure assessment in carcinogenic hazard identification: the IARC Monographs experience. Occup Environ Med. 81(7):366–72. https://doi.org/10.1136/oemed-2023-109277 PMID:39033030
6. DeBono NL, Daniels RD, Beane Freeman LE, Graber JM, Hansen J, Teras LR, et al. (2023). Firefighting and cancer: a meta-analysis of cohort studies in the context of cancer hazard identification. Saf Health Work. 14(2):141–52. https://doi.org/10.1016/j.shaw.2023.02.003 PMID:37389311
7. Turner MC, Cogliano V, Guyton K, Madia F, Straif K, Ward EM, et al. (2023). Research recommendations for selected IARC-classified agents: impact and lessons learned. Environ Health Perspect. 131(10):105001. https://doi.org/10.1289/EHP12547 PMID:37902675
8. Reisfeld B, de Conti A, El Ghissassi F, Benbrahim-Tallaa L, Gwinn W, Grosse Y, et al. (2022). kc-hits: a tool to aid in the evaluation and classification of chemical carcinogens. Bioinformatics. 38(10):2961–2. https://doi.org/10.1093/bioinformatics/btac189 PMID:35561175
9. Hodge JC, Netto GJ, Rekhi B, Cooper WA, Eden M, Field AS, et al. (2025). WHO Classification of Tumours: evolution of a global resource in the molecular era. Lancet Oncol. 26(4):410–3. https://doi.org/10.1016/S1470-2045(24)00709-5 PMID:40179904
10. Giesen C, Goldman-Levy G, Cree IA, Cierco Jimenez R, Machado A, Lokuhetty D (2024). WHO Classification of Tumours: moving towards the sixth edition. 86(6):839–44. Histopathology. https://doi.org/10.1111/his.15325 PMID:39293942
11. Colling R, Indave I, Del Aguila J, Jimenez RC, Campbell F, Chechlińska M, et al. (2024). A new Hierarchy of Research Evidence for Tumor Pathology: a Delphi study to define levels of evidence in tumor pathology. Mod Pathol. 37(1):100357. https://doi.org/10.1016/j.modpat.2023.100357 PMID:37866639
12. Colling R, Indave I, Del Aguilla J, Cierco Jimenez R, Campbell F, Chechlinska M, et al. (2024). Moving forward on tumor pathology research reporting: a guide for pathologists from the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group. Mod Pathol. 37(7):100515. https://doi.org/10.1016/j.modpat.2024.100515 PMID:38763419
13. Shafique A, Gonzalez R, Pantanowitz L, Tan PH, Machado A, Cree IA, et al. (2024). A preliminary investigation into search and matching for tumor discrimination in World Health Organization breast taxonomy using deep networks. Mod Pathol. 37(2):100381. https://doi.org/10.1016/j.modpat.2023.100381 PMID:37939901
14. Cree IA (2023). The new WHO cytopathology reporting systems – extending the WHO classification of tumors. J Am Soc Cytopathol. 12(4):239–42. https://doi.org/10.1016/j.jasc.2023.04.004 PMID:37244847
15. Milman T, Grossniklaus HE, Goldman-Levy G, Kivelä TT, Coupland SE, White VA, et al.; WHO Classification of Tumours Editorial Board (2023). The 5th edition of the World Health Organization Classification of Tumours of the Eye and Orbit. Ocul Oncol Pathol. 9(3–4):71–95. https://doi.org/10.1159/000530730 PMID:37900189
16. Gapstur S, Islami F, Lauby-Secretan B (2025). Alcohol. In: Jemal A, Sung H, Kelly K, Soerjomataram I, Bray F, editors. The cancer atlas. 4th ed. Atlanta (GA), USA: American Cancer Society; pp. 26–27. Available here
17. Gapstur SM, Mariosa D, Neamtiu L, Nethan ST, Rehm J, Huckle T, et al. (2025). The IARC perspective on the effects of policies on reducing alcohol consumption. N Engl J Med. 392(17):1752–9. https://doi.org/10.1056/NEJMsr2413289 PMID:40305721
18. Lauby-Secretan B (2025). Response to the current perspective: evaluation of screening mammography effectiveness: the IARC recommendations of 2015 need revision. Eur J Cancer. 226:115658. https://doi.org/10.1016/j.ejca.2025.115658 PMID:40729841
19. Rumgay H, Colombet M, Ramos da Cunha A, Filho AM, Warnakulasuriya S, Conway DI, et al. (2026). Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022. CA Cancer J Clin. 76(1):10.3322/caac.70048. https://doi.org/10.3322/caac.70048 PMID:41335400
20. Dossus L, Gunter MJ, Gonzalez-Gil EM, Lauby-Secretan B, Ahmadi N, Hursting S, et al. (2025). CUP Global Framework for the review of the biological pathways linking diet, nutrition, body weight, and physical activity with cancer incidence. Health Open Research. https://doi.org/10.21955/healthopenres.1115016.1